FDA Investigator Barbara A Gullick
Barbara A Gullick has conducted inspections on 135 sites in 1 countries as of 05 May 2008. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
135
Last Inspection Date:
05 May 2008
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Barbara A Gullick:
Alice S Tsao,
Alison N Stieg,
Allison E Sincek,
Amanda B Athey,
Amy C Amaro,
Anastasia M Shields,
Andrea L Williams Jones,
Ann Marie Karnick,
Anne E Johnson,
Anthony W Lee,
Ashley M Whitehurst,
Austin B Appler,
Barbara A Burke,
Barbara J Holladay,
Bijoy Panicker,
Brandon L Mariner,
Brooke K Higgins,
Bruce E Kummer,
Camilla S Smith,
Chaltu Nwakijra,
Charles D Boison,
Charles M Kerns, BLT DO,
Cherlita A Honeycutt,
Chiang Syin, PhD,
Christina K Theodorou,
Christine W Twohy,
Christopher D Leach,
Craig D Zagata,
Cynthia A Harris, MD, RN,
Daniel W Johnson,
David A Oluwo,
David P Rice, Jr,
Dennis R Hock,
Djamila Harouaka,
Douglas A Campbell,
Dr. Dominick Roselle,
Dr. Roslyn F Powers,
Dr. Yubing Tang,
Edette J Newby,
Edmund F Mrak, Jr,
Edward P Potter,
Edwin L Hobbs,
Elizabeth A Laudig,
Elvis D Morton,
Emest F Bizjak,
Emily A Walters,
Emmanuel A Dimaano, Jr,
Erika M Wilkerson,
Gail L Katz,
Gayle S Lawson,
George Pyramides,
Gerald Mierle,
Heath R Harley,
Hector Jcolon Torres,
Helen B Ricalde,
Holly S Simms,
Jaclyn N Munsch,
James M Mason,
James M Simpson,
James T Mccoy,
James W Leonette,
Jamie D Swann,
Jeanne D Shaffer,
Jeanne F Broderick,
Jeffrey A Reed,
Jeffrey A Sincek,
Jennifer A Jones,
Jessica D Nanini,
Joanne S Wilson,
Johnson,
Jonah S Ufferfilge,
Jonathan W Chapman,
Joseph W Matthews,
Julianne C Mccullough,
Julie A Silberberg,
Junho Pak,
Justin C Fuller,
Justin H Price,
Karen A Spencer,
Kathleen M Jordan,
Kenneth L Smalls,
Kenneth M Gordon,
Kenneth Nieves,
Kimberly A Dux,
Kip J Hanks,
Kish Bolden,
Ko U Min,
Krista N Flores,
Kristina L Conroy,
La Tasham Gunter,
Lakisha M Williams,
Laurie A Haxel,
Laurissa S Flowers,
Lawrence Harmon, Jr,
Lawrence J Stringer,
LCDR Anastasia M Piliafas Brown,
LCDR Cornelius Brown, III,
LCDR Wilfred A Darang,
Linda M Hoover,
Linda S Mattingly,
Lori A Holmquist,
Lori S Lawless,
Lorraine L Chavis,
Louis G An,
LT John M Mastalski,
LTJG Bradley E Benasutti,
Lucas B Leake,
Lynette P Salisbury,
Marcellinus D Dordunoo,
Marcus A Ray,
Margaret M Doherty,
Margaret Torres Vazquez,
Maricelys Mercado,
Marion W Nadeau,
Mary P Murphy,
Mary T Carden,
Matthew M Henciak,
Megan F Mclaughlin,
Megan M Lauff,
Melissa J Garcia,
Merideth K Rose,
Michael A Charles,
Michael Shanks, MS,
Michele M Falchek,
Michelle E Noonan Smith,
Mildred L Mccray,
Mohamad A Chahine,
Monique Rac Lester,
Myra L Gemmill,
Nancy L Meade,
Nancy L Rose,
Nebil A Oumer,
Nicholas A Violand,
Nicholas P Schaub,
Nikisha M Bolden,
Nina D Patel,
Normica G Facey,
Osama M Hamoud,
Patricia A Morrow,
Paula J Bretz,
Peter R Lenahan,
Philip W Beck,
Rachael O Oyewole,
Rachel C Harrington,
Regina Gibson Melton,
Richard J Bashay,
Robert E Davis,
Robert J Martin,
Rterry Bolen,
Sharon K Thoma, PharmD,
Shirshendu K Deb, PhD,
Shusheen A Alexander,
Simone E Pitts,
Stacey A Priest,
Stephanie L Shapley,
Stephanie Mangigian, MS/OSH, RN,
Stephany J Wesley,
Stephen R King,
Susan M Miller,
Suzanne M Healy,
Tamika E Allen, RN,
Tania E Vizcaino,
Teresa L Fox,
Tonia F Bernard,
Toniette K Williams,
Toyin B Oladimeji,
Valeria A Moore,
Valerie G Vallely,
Viviana Matta,
Vivin George,
Walter L Fava,
Wanda Y Fields,
Wanda Y Honeyblue,
William D Bassett, Jr,
Willy A Orantes,
Yvins Dezan,
Zachary L Miller,
Zhongren Wu
Barbara A Gullick's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| June, 2008 | FDA 483 | American Natl. Red Cross-Greater Chesapeake & Potomac Region - Form 483, 2008-06-23 |
| June, 2001 | FDA 483 | Sitek Research Laboratories - Form 483, 2001-06-07 |
| May, 2005 | FDA 483 | BRT Laboratories, Inc. - Form 483, 2005-05-24 |
| April, 2003 | EIR | Culligan Water Company of Maryland, Inc. - EIR, 2003-04-02 |
| November, 2002 | FDA 483 | Pharmaceutics International, Inc. - Form 483, 2002-11-14 |
| June, 2001 | EIR | Sitek Research Laboratories - EIR, 2001-06-07 |
| November, 2002 | FDA 483 Response | Pharmaceutics International, Inc. - Form 483R, 2002-11-14 |
| November, 2002 | EIR | Pharmaceutics International, Inc. - EIR, 2002-11-14 |
| May, 2003 | EIR | Baltimore Washington Medical Center - EIR, 2003-05-29 |
| July, 2008 | FDA 483 | American Red Cross Biomedical Services Headquarters - Form 483, 2008-07-03 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more